Moreover, therapeutic inhibition of Chop in CD8+ T cells, through specific anti-sense oligonucleotides, dramatically augmented the anti-tumor effectiveness of T cell-based adoptive transfer therapies. The gene discussed is CD8A; the disease is neoplasm.